Shukla Usha, Singh Dheer, Singh Jheelam, Yadav Jay Brijesh Singh
Anaesthesiology and Critical Care, Uttar Pradesh University of Medical Sciences, Etawah, IND.
Anaesthesiology, Uttar Pradesh University of Medical Sciences, Etawah, IND.
Cureus. 2022 May 22;14(5):e25225. doi: 10.7759/cureus.25225. eCollection 2022 May.
Background Dexmedetomidine, fentanyl, and tramadol as an adjuvant to local anesthetics improve postoperative analgesia when used in epidural anesthesia. We aimed to compare the efficacy of dexmedetomidine, fentanyl, and tramadol as an adjuvant to levobupivacaine in epidural anesthesia. Materials and methods This was a double-blinded randomized clinical trial (RCT). One-hundred twenty patients of either sex, aged 18-60 years, American Society of Anesthesiologists (ASA) physical status classification I and II, undergoing elective orthopedic procedures under epidural anesthesia were allocated into four groups of 30 each. The dexmedetomidine group received 15 ml of 0.5% levobupivacaine and 25 μg in 2 ml of dexmedetomidine, the fentanyl group received 15 ml of 0.5% levobupivacaine and 50 μg in 2 ml of fentanyl, the Tramadol group received 15 ml of 0.5% levobupivacaine and 100 mg of tramadol in 2 ml, and the control group received 15 ml of 0.5% levobupivacaine and 2 ml normal saline. Patients were monitored for the total duration of analgesia, time of first analgesic requirement, time to reach the T-10 level of sensory block, two-segment regression time of the sensory block, time to reach the motor block (Bromage 3), time to motor regression (Bromage 2), visual analog scale (VAS) scores at 0, 15 minutes, 30 minutes, and the first, second, sixth, twelfth, and twenty-fourth hours postoperatively, total analgesic consumption in 24 hours, and complications, if any, were recorded. Results During the inter-group comparison, VAS scores were lower, the duration of analgesia was longer, and the total analgesic consumption was less in the dexmedetomidine group compared to the fentanyl, tramadol, and control groups. The time to onset of sensory block to T-10 and the attainment of motor block up to Bromage 3 was lower in the dexmedetomidine group. Two segment regression and regression of motor block to Bromage score 2 was lowest for the dexmedetomidine group compared to the other groups. A lower incidence of hypotension and bradycardia was noted with dexmedetomidine. Conclusions Dexmedetomidine is the better alternative as an adjuvant to epidural anesthesia, with faster onset, good quality, and prolonged duration with no relevant adverse effects.
右美托咪定、芬太尼和曲马多作为局部麻醉药的辅助用药,用于硬膜外麻醉时可改善术后镇痛效果。我们旨在比较右美托咪定、芬太尼和曲马多作为左旋布比卡因硬膜外麻醉辅助用药的疗效。
这是一项双盲随机临床试验(RCT)。120例年龄在18至60岁之间、美国麻醉医师协会(ASA)身体状况分级为I级和II级、接受硬膜外麻醉下择期骨科手术的患者,被随机分为四组,每组30例。右美托咪定组接受15 ml 0.5%左旋布比卡因和2 ml含25 μg右美托咪定的溶液,芬太尼组接受15 ml 0.5%左旋布比卡因和2 ml含50 μg芬太尼的溶液,曲马多组接受15 ml 0.5%左旋布比卡因和2 ml含100 mg曲马多的溶液,对照组接受15 ml 0.5%左旋布比卡因和2 ml生理盐水。监测患者的总镇痛时间、首次需要镇痛的时间、达到T-10感觉阻滞平面的时间、感觉阻滞的两个节段消退时间、达到运动阻滞(布罗玛分级3级)的时间、运动阻滞消退(布罗玛分级2级)的时间、术后0、15分钟、30分钟以及第1、2、6、12和24小时的视觉模拟评分(VAS)、24小时内的总镇痛药物消耗量,并记录并发症(如有)。
组间比较时,右美托咪定组的VAS评分更低,镇痛持续时间更长,总镇痛药物消耗量更少。右美托咪定组达到T-10感觉阻滞的起效时间和达到布罗玛分级3级运动阻滞的时间更短。与其他组相比,右美托咪定组感觉阻滞两个节段的消退和运动阻滞消退至布罗玛分级2级的时间最短。右美托咪定组低血压和心动过缓的发生率较低。
右美托咪定作为硬膜外麻醉的辅助用药是更好的选择,起效更快,质量良好,持续时间延长,且无相关不良反应。